group contrasts were tested using least-squares means two-tailed t -tests with BH correction
10.31083/FBL25586 Front Biosci
Several commonly prescribed medications inhibit the norepinephrine transporter and can significantly worsen hyperadrenergic POTS: SNRIs (duloxetine, venlafaxine) block norepinephrine reuptake, increasing the very neurotransmitter that is already in excess
Masi A, Quintana DS, Glozier N et al (2015) Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis
Improves Glycemic Control : This medication helps lower blood sugar levels by enhancing insulin sensitivity, making it beneficial for managing type 2 diabetes
Keywords: Stroke, type 2 diabetes mellitus, glucagon-like peptide 1 receptor agonists, cerebrovascular circulation, neuroprotection Key messages GLP-1 receptor agonist (GLP-1RA) therapy should be incorporated into a broad approach for risk reduction for stroke in patients with type 2 DM, especially in situations where prevention of ischaemic stroke is of high importance
.png)
